LEONCINI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 22.612
EU - Europa 18.601
AS - Asia 8.917
SA - Sud America 1.766
AF - Africa 208
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 15
Totale 52.165
Nazione #
US - Stati Uniti d'America 22.369
GB - Regno Unito 4.570
RU - Federazione Russa 3.919
CN - Cina 3.518
SG - Singapore 2.727
IE - Irlanda 2.662
IT - Italia 1.605
BR - Brasile 1.496
UA - Ucraina 1.323
SE - Svezia 1.321
DE - Germania 1.276
FR - Francia 847
HK - Hong Kong 815
VN - Vietnam 621
FI - Finlandia 453
KR - Corea 379
IN - India 222
TR - Turchia 171
CA - Canada 139
ES - Italia 122
AR - Argentina 111
BE - Belgio 94
BD - Bangladesh 88
AT - Austria 78
MX - Messico 67
NL - Olanda 67
IQ - Iraq 62
PL - Polonia 62
ZA - Sudafrica 58
EC - Ecuador 56
JP - Giappone 48
KE - Kenya 41
ID - Indonesia 39
AU - Australia 38
CZ - Repubblica Ceca 34
CI - Costa d'Avorio 32
PK - Pakistan 27
SA - Arabia Saudita 26
RO - Romania 24
UZ - Uzbekistan 24
CO - Colombia 22
CH - Svizzera 21
IL - Israele 21
LT - Lituania 19
MA - Marocco 18
VE - Venezuela 18
AE - Emirati Arabi Uniti 17
EG - Egitto 16
GR - Grecia 16
EU - Europa 15
PE - Perù 15
KZ - Kazakistan 14
PY - Paraguay 14
UY - Uruguay 14
AZ - Azerbaigian 13
CL - Cile 13
IR - Iran 12
HU - Ungheria 10
KG - Kirghizistan 10
NP - Nepal 10
AL - Albania 9
JO - Giordania 9
LV - Lettonia 9
PA - Panama 9
PH - Filippine 9
DO - Repubblica Dominicana 8
DZ - Algeria 8
RS - Serbia 8
TN - Tunisia 8
HR - Croazia 7
MY - Malesia 7
PT - Portogallo 7
UG - Uganda 7
AM - Armenia 6
BO - Bolivia 6
DK - Danimarca 6
BG - Bulgaria 5
ET - Etiopia 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
BY - Bielorussia 4
EE - Estonia 4
BA - Bosnia-Erzegovina 3
GT - Guatemala 3
JM - Giamaica 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
NG - Nigeria 3
OM - Oman 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
CR - Costa Rica 2
CU - Cuba 2
GA - Gabon 2
HN - Honduras 2
KW - Kuwait 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
Totale 52.135
Città #
Southend 4.157
Dublin 2.616
Fairfield 2.593
Dallas 2.410
Ashburn 1.662
Singapore 1.435
Chandler 1.289
Houston 1.250
Woodbridge 1.201
Jacksonville 1.129
Beijing 1.121
Moscow 1.094
Santa Clara 1.063
Wilmington 975
Seattle 965
Cambridge 801
Hong Kong 790
Ann Arbor 760
Siena 757
Princeton 524
Hefei 390
Seoul 371
New York 364
Dearborn 363
Nanjing 347
Los Angeles 280
Munich 255
Menlo Park 251
Dong Ket 199
San Mateo 189
Ho Chi Minh City 176
The Dalles 168
Boardman 160
San Diego 160
Helsinki 151
Shanghai 150
Buffalo 142
Nanchang 137
São Paulo 133
Izmir 114
Florence 107
Brussels 93
Málaga 88
Turku 83
San Francisco 74
Redondo Beach 73
Shenyang 72
Hanoi 71
London 71
Chicago 64
Columbus 62
Milan 62
Tianjin 62
Kunming 61
Fremont 57
Bengaluru 55
Changsha 53
Hebei 52
Toronto 52
Brooklyn 50
Lappeenranta 50
Montreal 50
Vienna 50
Warsaw 50
Council Bluffs 49
Jinan 47
Düsseldorf 46
Phoenix 46
Denver 43
Norwalk 41
Tokyo 41
Rio de Janeiro 40
Jiaxing 39
San Jose 38
Atlanta 37
Guangzhou 36
Rome 36
Johannesburg 35
Poplar 35
Frankfurt am Main 34
Orem 34
Washington 34
Belo Horizonte 33
Chennai 33
Abidjan 32
Hangzhou 30
Falls Church 29
Philadelphia 29
Stockholm 28
Ningbo 27
Zhengzhou 27
Brno 26
Nuremberg 26
Guayaquil 25
Sezze 25
Nairobi 24
Manchester 23
Tashkent 23
Amsterdam 22
Boston 22
Totale 35.849
Nome #
Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach 548
The surgical pathology laboratory in Mwanza, Tanzania: A survey on the reproducibility of diagnoses after the first years of autonomous activity 533
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 414
p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape 372
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression 315
MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma 313
Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded microRNAs expression in EBER-negative Burkitt lymphoma cases 306
Frequent Traces of EBV Infection in Hodgkin and non-Hodgkin Lymphomas Classified as EBV-negative by Routine Methods: Expanding the Landscape of EBV-related Lymphomas 306
How in-depth histological look may allow challenging diagnosis: The case of a primary in situ mantle cell neoplasm of the appendix 302
Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type 302
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. 300
Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature 299
Analisi del riarrangiamento e delle mutazioni del gene VH delle immunoglobuline nelle cellule B monocitoidi M-IRTA-1 positive. 298
Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic burkitt lymphoma suggests antigen drive activation of bcr as opposed to sporadic burkitt lymphoma 297
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma 291
Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity 289
Analysis of the IgVH genes in T cell-mediated and antibody-mediated rejection of the kidney graft. 287
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. 285
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues. 283
Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal 279
The alteration of lipid metabolism in burkitt lymphoma identifies a novel marker: adipophilin 277
Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia 275
Epstein-Barr virus-induced metabolic rearrangements in human B-cell lymphomas 272
Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases 270
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 269
Alteration of microRNAs regulated by c_Myc in Burkitt lymphoma 262
Human peripheral blood lymphocytes and fibroblasts as Notch3 expression models. 259
Apoptotic index: Discriminant feature for the differentiation of cutaneous diffuse malignant follicular center cell lymphomas from lymphoid hyperplasia 257
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.). 253
Burkitt lymphoma versus diffuse large B-cell lymphoma: A practical approach 252
Interplay between the epigenetic enzyme lysine (K)-specific demethylase 2B and Epstein-Barr virus infection 250
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 249
Pathobiologic roles of epstein–barr virus-encoded microRNAs in human lymphomas 246
A review of the trends of lymphomas in the equatorial belt of Africa 244
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus 243
The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization 241
Lack of p66Shc in the CLL mouse model E mu-TCL1 exacerbates nodal and extranodal infiltration of leukemic cells which can undergo Richter's transformation 240
The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma 239
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1 239
Abortive mitoses and nuclear DNA fragmentation in CD30+ large cells of Hodgkin's disease 238
Aggressive B-cell lymphomas 237
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation 236
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 236
Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia. 235
HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas 232
Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells 231
EBV reactivation influences clonal evolution in HHV8 related lymphoprolipherative disorders? 231
Overlapping morphologic and immunophenotypic profiles in small B-cell lymphoma. A report of two cases. 229
Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors 229
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes 228
Analisi citofluorimetrica del contenuto di DNA nel carcinoma gastrico 227
Burkitt’s lymphoma: new insights into molecular pathogenesis 225
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas 225
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. 225
Correlation between MYC gene rearrangement and MYC protein expression suggests that MYC regulation is more complex than previously known 224
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? 223
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. 222
Comparison between the monoclonal antibodies Ki‐67 and PC 10 in 125 malignant lymphomas 221
Aggressive B-cell lymphomas: a review based on the Workshop of the XI Meeting of the European Association for Haematopathology 220
Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva 220
A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients 220
The effects of HIV 1 Tat Protein on cell cycle during cervical carcinogenesis 218
Analysis of rearrangement and Vh gene mutations and correlation with the expression of M-IRTA 1 in monocytoid B cells of toxoplasmic lymphadenitis. 216
Identification of single-nucleotide variants by high-throughput RNA sequencing in endemic Burkitt Lymphoma 215
Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma 213
Gene expression analysis uncovers similarty and differences among Burkitt lymphoma subtypes 212
Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program 212
Anaplastic large cell lymphomas and Hodgkin's disease: distinctive growth features and expression of p34cdc2 /cyclin B-1 211
High incidence of familial gastric cancer in Tuscany, a region in Italy. 211
Anaplastic large cell lymphomas and Hodkin’s disease: distinctive growth features and expression of p34cdc2/cyclin B-1 211
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an italian family 211
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases 210
Distribution of cytoskeletal and contractile proteins in normal and tumour bearing salivary and lacrimal glands 209
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in anti-apoptotic and chromatin-remodeling genes. 208
Cell Kinetics, Morphology, and Molecular IgVH Gene Rearrangements in Hodgkin's Disease 208
Phenotypic overlaps between pleomorphic malignant T‐cell lymphomas and mixed‐cellularity Hodgkin's disease 207
Urocortin expression is downregulated in human endometrial carcinoma 205
Spatial distribution of mitosis, apoptosis and small blood vessels in malignant diffuse follicular‐center‐cell lymphomas: A nearest‐neighbor analysis 205
Placental neurokinin B mRNA expression increases at preterm labor 204
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 203
Hodgkin's lymphoma: The pathologist's viewpoint 203
pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade 203
The role of the Cdk9/Cyclin T1 complex in T cell differentiation 202
Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines 201
Growth vs. DNA strand breaks in Hodgkin's disease: Impaired proliferative ability of Hodgkin and Reed-Sternberg cells 201
Growth patterns of diffuse non-Hodgkin's lymphomas estimated from mitotic and apoptotic indices 200
Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity 200
CDK9/Cyclin T expression in reactive lymph nodes and malignant lymphomas. 198
The tumor virus landscape of AIDS-related lymphomas 198
Immunoglobulin gene rearrangement analysis in composite Hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? 198
Epstein-Barr virus infection in sinonasal non-Hodgkin's lymphomas 195
Identification of monoclonal B-cell populations in lymphoid infiltrates of lacrimal gland by rapid cycle polymerase chain-reaction 193
null 193
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis 192
Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women 192
Low versus high cell turnover in diffusely growing non‐Hodgkin's lymphomas 191
Distinction between diffuse cutaneous malignant follicular center cell lymphoma and lymphoid hyperplasia by computerized nuclear image analysis 190
Antigen retrieval techniques in immunohistochemistry: Comparison of different methods 190
Pathological case of the month - Multifocal Rosai-Dorfman disease of soft tissue 189
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 189
Totale 24.377
Categoria #
all - tutte 163.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.263


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.599 0 0 0 0 0 646 296 899 510 416 390 442
2021/20223.804 291 492 278 344 182 88 151 225 166 416 312 859
2022/20235.096 327 377 735 647 492 1.073 121 414 519 132 161 98
2023/20243.902 155 114 347 149 117 1.158 1.344 49 33 125 36 275
2024/20257.348 179 445 739 395 980 366 98 319 587 356 861 2.023
2025/202612.381 1.407 2.562 1.878 2.479 3.608 447 0 0 0 0 0 0
Totale 52.897